{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:48:17Z","timestamp":1787683697544,"version":"build-2784847793"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T00:00:00Z","timestamp":1370908800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0065144","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T17:21:41Z","timestamp":1370971301000},"page":"e65144","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["Gene Expression Profiling of Ampullary Carcinomas Classifies Ampullary Carcinomas into Biliary-Like and Intestinal-Like Subtypes That Are Prognostic of Outcome"],"prefix":"10.1371","volume":"8","author":[{"given":"Michael J.","family":"Overman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiexin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Kopetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Zhi-Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Stemke-Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"R\u00fcmmele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pilarsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gr\u00fctzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Abbruzzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauri","family":"Varadhachary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Broom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huamin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,6,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ejso.2008.10.010","article-title":"Assessment of survival advantage in ampullary carcinoma in relation to tumour biology and morphology","volume":"35","author":"G Morris-Stiff","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejso.2008.01.030","article-title":"An audit of outcomes of a series of periampullary carcinomas","volume":"35","author":"PO Berberat","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Jiang Z VG, Wang X, Kopetz S, Lee JE, et al.. (2013) Retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine based chemotherapy. Annals of Oncology. In press.","DOI":"10.1093\/annonc\/mdt191"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1349-7006.1994.tb02077.x","article-title":"Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater","volume":"85","author":"W Kimura","year":"1994","journal-title":"Jpn J Cancer Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1309\/AJCPCTCUQSYI89YT","article-title":"Phenotypic and genotypic characterization of carcinomas of the papilla of Vater has prognostic and putative therapeutic implications","volume":"135","author":"I Kohler","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2407-8-170","article-title":"Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma","volume":"8","author":"A Westgaard","year":"2008","journal-title":"BMC Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/PAS.0b013e3181983ef7","article-title":"Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions","volume":"33","author":"P Ruemmele","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2012.7352","article-title":"Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial","volume":"308","author":"JP Neoptolemos","year":"2012","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00534-004-0898-3","article-title":"Pathogenesis of carcinoma of the papilla of Vater","volume":"11","author":"HP Fischer","year":"2004","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00000478-200407000-00005","article-title":"Carcinoma of the ampulla of Vater: comparative histologic\/immunohistochemical classification and follow-up","volume":"28","author":"H Zhou","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"ref11","first-page":"1641","article-title":"The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis","volume":"54","author":"YH Roh","year":"2007","journal-title":"Hepatogastroenterology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00428-007-0444-1","article-title":"Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability","volume":"451","author":"F Sessa","year":"2007","journal-title":"Virchows Arch"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1200\/JCO.2005.03.068","article-title":"Expression of the caudal-type homeodomain transcription factors CDX 1\/2 and outcome in carcinomas of the ampulla of Vater","volume":"23","author":"DE Hansel","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/(SICI)1097-0142(19990815)86:4<596::AID-CNCR8>3.0.CO;2-H","article-title":"Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater","volume":"86","author":"H Matsubayashi","year":"1999","journal-title":"Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/annonc\/mdn558","article-title":"Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients","volume":"20","author":"B Vincenzi","year":"2009","journal-title":"Ann Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/annonc\/mdm576","article-title":"Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer","volume":"19","author":"D Santini","year":"2008","journal-title":"Ann Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1093\/nar\/gng015","article-title":"Summaries of Affymetrix GeneChip probe level data","volume":"31","author":"RA Irizarry","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1158\/1535-7163.MCT-09-0743","article-title":"Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set","volume":"9","author":"ES Park","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1158\/0008-5472.CAN-07-6854","article-title":"An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer","volume":"68","author":"K Stemke-Hale","year":"2008","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1432-1033.1997.00225.x","article-title":"Cloning and expression of the mRNA of human galectin-4, an S-type lectin down-regulated in colorectal cancer","volume":"248","author":"H Rechreche","year":"1997","journal-title":"Eur J Biochem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jama.2009.141","article-title":"Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer","volume":"301","author":"SA Waldman","year":"2009","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1006\/bbrc.1997.6966","article-title":"Characterization of posttranslational modifications of human A33 antigen, a novel palmitoylated surface glycoprotein of human gastrointestinal epithelium","volume":"236","author":"G Ritter","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1139\/bcb-76-6-957","article-title":"The Cdx-1 and Cdx-2 homeobox genes in the intestine","volume":"76","author":"JN Freund","year":"1998","journal-title":"Biochem Cell Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/jcp.2003.013292","article-title":"MUC1 and MUC2 in pancreatic neoplasia","volume":"57","author":"E Levi","year":"2004","journal-title":"J Clin Pathol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/onc.2010.526","article-title":"MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition","volume":"30","author":"LD Roy","year":"2011","journal-title":"Oncogene"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0065-230X(09)05005-2","article-title":"Clusterin and chemoresistance","volume":"105","author":"JY Djeu","year":"2009","journal-title":"Adv Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1477-7819-9-59","article-title":"Clusterin confers gmcitabine resistance in pancreatic cancer","volume":"9","author":"Q Chen","year":"2011","journal-title":"World J Surg Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/SLA.0b013e31821994a8","article-title":"Hepatocyte nuclear factor (HNF) 4alpha expression distinguishes ampullary cancer subtypes and prognosis after resection","volume":"254","author":"F Ehehalt","year":"2011","journal-title":"Ann Surg"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1158\/1535-7163.MCT-06-0650","article-title":"Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study","volume":"6","author":"UT Shankavaram","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1074\/mcp.M400055-MCP200","article-title":"Integrated genomic and proteomic analyses of gene expression in Mammalian cells","volume":"3","author":"Q Tian","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2008.19.7145","article-title":"Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater","volume":"27","author":"MJ Overman","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"J Valle","year":"2010","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1371\/annotation\/6afdd046-e1a7-4421-b7ec-0c9492ce2544","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,7,3]],"date-time":"2013-07-03T00:00:00Z","timestamp":1372809600000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0065144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T12:13:27Z","timestamp":1540210407000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0065144"}},"subtitle":[],"editor":[{"given":"Ju-Seog","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,11]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0065144","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/6afdd046-e1a7-4421-b7ec-0c9492ce2544","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,11]]}}}